Genfit (GNFT) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free GNFT Stock Alerts €3.48 +0.01 (+0.29%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 26, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%April 8, 2024 | markets.businessinsider.comBuy Rating Reiterated for Genfit SA Amidst Promising Clinical Developments and Strong Financial OutlookApril 5, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week LowerApril 5, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Genfit SA (GNFT) and Laboratory (LH)February 15, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday TradingFebruary 14, 2024 | markets.businessinsider.comGenfit (GNFTF) Gets a Buy from Kepler CapitalJanuary 20, 2024 | finance.yahoo.comGenfit S.A. (GNFT.PA)January 15, 2024 | finance.yahoo.comGENFIT Announces 2024 Financial CalendarDecember 11, 2023 | markets.businessinsider.comBuy Rating Affirmed for Genfit SA Amid Favorable Regulatory Developments and Positive Trial ResultsDecember 6, 2023 | finance.yahoo.comGENFIT Announces Publication in the Journal of Hepatology on the Accurate Performance of NIS2+™ as a Screening Tool for the Enrollment of Patients in MASH Clinical TrialsNovember 16, 2023 | finance.yahoo.comGENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023November 13, 2023 | msn.comGenfit stock rallies 20% after hours on data for liver disease drugNovember 12, 2023 | markets.businessinsider.comKepler Capital Sticks to Its Buy Rating for Genfit (GNFTF)November 10, 2023 | finanznachrichten.deGENFIT S.A.: GENFIT Reports Third Quarter 2023 Financial InformationNovember 2, 2023 | finance.yahoo.comGENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023November 1, 2023 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Wednesday TradingAugust 14, 2023 | msn.comUBS starts Cymabay at buy, expecting positive Phase 3 data for seladelparAugust 11, 2023 | finance.yahoo.comGENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology CommunicationsJuly 3, 2023 | markets.businessinsider.comAnalyst Expectations for Genfit's FutureJune 30, 2023 | msn.comGenfit gains as Phase 3 trial for liver disease candidate succeeds (update)June 30, 2023 | markets.businessinsider.comIpsen, GENFIT Reveal Positive Phase III Trial Results Of Elafibranor In Patients With PBCJune 4, 2023 | msn.comGenfit (EPA:GNFT) Price Target Decreased by 11.94% to 8.02May 24, 2023 | finance.yahoo.comGENFIT: May 24, 2023 Combined Shareholders Meeting resultsMay 12, 2023 | finanznachrichten.deGENFIT S.A.: GENFIT Reports First Quarter 2023 Financial InformationMay 11, 2023 | msn.comGenfit: Major Data Release Before End Of Q2 Of 2023 Could Get Ball RollingMay 11, 2023 | finance.yahoo.comGENFIT Reports First Quarter 2023 Financial InformationApril 27, 2023 | finance.yahoo.comGENFIT Announces Publication of Extra-Financial Performance Report 2022April 21, 2023 | msn.comEuropean Equities Move Modestly Higher in Friday Trading, But Set to End Week LowerApril 18, 2023 | msn.comEuropean Equities Nudge Higher in Tuesday Trading on Rising Bank, Pharma StocksApril 18, 2023 | finance.yahoo.comGENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-FApril 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Kronos Bio (KRON), Genfit SA (GNFT) and Talaris Therapeutics (TALS)April 14, 2023 | finanznachrichten.deGENFIT S.A.: GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate UpdateApril 13, 2023 | finance.yahoo.comGENFIT Reports Full-Year 2022 Financial Results and Provides Corporate UpdateMarch 1, 2023 | finance.yahoo.comGENFIT Announces Revenues and Cash Position as of December 31, 2022January 3, 2023 | msn.comFinancial, Pharma Gains Spur European Equities Higher in Tuesday TradingJanuary 1, 2023 | thestreet.comGenfit's Fatty Liver Drug Study Results Are Coming. Here's What You Need to Know.November 18, 2022 | technews.tmcnet.comGENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver DiseasesNovember 10, 2022 | finance.yahoo.comGENFIT Reports Third Quarter 2022 Financial InformationOctober 27, 2022 | msn.comEuropean ADRs Move Higher in Wednesday TradingOctober 12, 2022 | reuters.comGNFT.O - Genfit SA (ADR) | Stock Price & Latest News | ReutersJune 14, 2022 | seekingalpha.comGNFT Genfit S.A.May 25, 2022 | finance.yahoo.comGENFIT: May 25, 2022 Combined Shareholders Meeting resultsMay 11, 2022 | seekingalpha.comGenfit reports Q1 resultsMay 11, 2022 | finance.yahoo.comGENFIT Reports First Quarter 2022 Financial Information (Unaudited financial information under IFRS)April 29, 2022 | finance.yahoo.comGENFIT Announces Publication of the 2021 Universal Registration Document; the 2021 Annual Report on Form 20-F and Availability of Preparatory Documents for the Annual Combined Shareholders Meeting on May 25, 2022April 14, 2022 | finance.yahoo.comWhat Makes GENFIT S.A. Unsponsored ADR (GNFT) a New Buy StockApril 11, 2022 | benzinga.comSVB Leerink Maintains Outperform on Genfit, Lowers Price Target to $10April 7, 2022 | seekingalpha.comGenfit GAAP EPS of €1.23, revenue of €85.58MApril 7, 2022 | nz.finance.yahoo.comGENFIT Reports Full-Year 2021 Financial Results and Provides Corporate UpdateJanuary 25, 2022 | nasdaq.comGENFIT S.A. American Depositary Shares (GNFT) Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. GNFT Media Mentions By Week GNFT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNFT News Sentiment▼0.000.50▲Average Medical News Sentiment GNFT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNFT Articles This Week▼00▲GNFT Articles Average Week Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fielmann Group News Fresenius SE & Co. KGaA News Sanofi News Sartorius Aktiengesellschaft News Sartorius Stedim Biotech News Medigene News MorphoSys News Drägerwerk AG & Co. KGaA News Stratec News CompuGroup Medical SE & Co. KGaA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:GNFT) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA once-in-a-century investment opportunityStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genfit S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
